Chad Beyer

Chad Beyer is a highly accomplished professional with a diverse educational background and extensive experience in the pharmaceutical industry.

He holds a PhD in Neuropharmacology from Louisiana State University Health Sciences Center, an MBA in Pharmaceutical Management from Rutgers Business School, and a BS in Psychology and Bioethics from Allegheny College.

Chad has held significant leadership roles in various organizations, including serving as the Chief Executive Officer at Kures, the Entrepreneur In Residence at Lafayette College, the SVP of R&D at Promentis Pharmaceuticals, and the President & CEO at Promentis Pharmaceuticals.

His experience also includes positions as the Vice President of Research & Development at Ariel Pharmaceuticals, Drug Development Consultant at Solomon Therapeutics, Head of Neurochemistry at Wyeth Pharmaceuticals, and Principal Research Scientist at Wyeth Pharmaceuticals.